SIESTA Rehab Education for Stroke Recovery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve stroke recovery by enhancing sleep during rehabilitation. Researchers are testing a program called SIESTA Rehab Education, which trains nurses to minimize nighttime disruptions and screen patients for sleep disorders. The trial includes two groups: one receiving the sleep-focused treatment and a control group receiving regular care. Stroke patients staying at the Shirley Ryan AbilityLab may qualify for this study. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance stroke recovery through better sleep.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this protocol is safe for stroke patients?
Research shows that the SIESTA Rehab Education program aims to improve sleep for stroke patients. It achieves this by training nurses to avoid unnecessary nighttime disturbances and by screening patients for sleep-related breathing issues. Studies on SIESTA report no safety issues or negative effects from these sleep methods. Instead, they highlight positive feedback from staff, indicating that the program is well-received and effective in hospitals.
The trial is labeled as "Not Applicable" for a phase, likely indicating the use of behavioral methods, such as sleep education, rather than medications or surgeries. These methods are generally considered low-risk. However, without specific safety data, concrete evidence about safety concerns cannot be provided.12345Why are researchers excited about this trial?
Researchers are excited about the SIESTA Rehab Education because it focuses on minimizing nighttime disruptions for stroke patients, which is a novel approach compared to standard care that doesn't emphasize sleep preservation. Unlike typical stroke recovery treatments, which often center on medication and physical rehabilitation, SIESTA aims to optimize the healing environment by training nurses to batch tasks and screen for sleep disorders like sleep apnea. By prioritizing quality sleep, this method could enhance recovery, potentially leading to improved outcomes for stroke patients.
What evidence suggests that the SIESTA Rehab Education and ApneaLink interventions could be effective for stroke recovery?
Research shows that stroke patients often struggle with sleep during recovery, which can hinder their progress. This trial tests the SIESTA-Rehab Education program as an intervention by training nurses to reduce nighttime disturbances and address sleep-related breathing issues. Studies have found that better sleep can enhance recovery for stroke patients. By focusing on improved sleep, the SIESTA-Rehab program aims to support recovery by aiding brain healing, enhancing movement skills, and protecting the brain. Early results suggest that this approach could improve both sleep and recovery for stroke patients.14678
Are You a Good Fit for This Trial?
This trial is for adults over 18 who've had a stroke and are admitted to the Shirley Ryan AbilityLab. They must be able to consent, follow study procedures, and have medical clearance. It's not for those with serious heart conditions, neurological diseases like MS or Alzheimer's, pregnant/nursing women, people with skin allergies/open wounds, or users of certain cardiac devices.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive sleep-promoting interventions including nursing education and screening for sleep-disordered breathing during acute stroke rehabilitation
Follow-up
Participants are monitored for sleep quality and rehabilitation outcomes post-discharge
What Are the Treatments Tested in This Trial?
Interventions
- ApneaLink
- SIESTA Rehab Education
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor
Shirley Ryan AbilityLab
Collaborator
Northwestern University
Collaborator